27 studies found for:    " December 07, 2011":" January 06, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma
Conditions: HIV;   Burkitt's Lymphoma
Interventions: Drug: Induction Phase;   Drug: Consolidation Phase (on day +50);   Drug: Intensification phase;   Drug: BEAM conditioning;   Radiation: Consolidation radiotherapy
2 Active, not recruiting Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/GS-7340 Single Tablet Regimen Versus Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen in HIV 1 Infected, Antiretroviral Treatment-Naive Adults
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: E/C/F/TAF;   Drug: E/C/F/TDF;   Drug: Placebo to match E/C/F/TAF;   Drug: Placebo to match E/C/F/TDF
3 Active, not recruiting Phase 3b Open Label Study to Evaluate Switching From Regimens Consisting of a Non-nucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV 1 Infected Patients
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: Stribild;   Drug: TVD;   Drug: NNRTI
4 Completed Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men
Conditions: Human Immunodeficiency Virus Infection;   Sexually Transmitted Diseases
Interventions: Behavioral: Men Making a Difference HIV/STD Risk Reduction Intervention;   Behavioral: Health Promotion Control
5 Completed Safety and Immunogenicity Study of HIV-MAG Vaccine +/- IL-12 and Ad35-GRIN/ENV in HIV-uninfected Volunteers
Condition: HIV Infections
Interventions: Biological: HIV-MAG (3,000mcg);   Biological: GENEVAX® IL-12 (100mcg);   Biological: GENEVAX® IL-12 (1000mcg);   Biological: Ad35-GRIN/ENV
6 Completed Telephone-delivered Behavioral Interventions to Reduce Risky Sexual Behavior in HIV-positive Late Middle-age and Older Adults
Condition: Unsafe Sex
Interventions: Behavioral: 1-session of telephone-administered motivational interviewing;   Behavioral: 4-session telephone-administered motivational interviewing
7 Recruiting Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence
Condition: HIV Infection
Interventions: Drug: Immediate ARV treatment initiation with TDF/FTC/EFV;   Other: South African recommendation guided ARV (TDF/FTC/EFV) initiation
8 Recruiting Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women
Condition: HIV Infection
Interventions: Drug: Maraviroc;   Drug: Emtricitabine;   Drug: Tenofovir disoproxil fumarate;   Other: Maraviroc placebo;   Other: Emtricitabine placebo;   Other: Tenofovir disoproxil fumarate placebo
9 Completed Couple-oriented Prenatal HIV Counseling in Low and Medium HIV Prevalence Countries
Conditions: Partner HIV Testing;   Couple HIV Counseling;   Couple Communication;   HIV Incidence
Intervention: Behavioral: Couple-oriented post-test HIV counseling
10 Active, not recruiting
Has Results
A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Dolutegravir
11 Completed Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Ortho-Cyclen;   Drug: Dolutegravir;   Drug: Placebo
12 Not yet recruiting Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women
Condition: HIV Infections
Interventions: Drug: 1% tenofovir gel;   Drug: Placebo gel
13 Recruiting Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Isoniazid (INH);   Drug: Placebo for isoniazid (INH)
14 Recruiting Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children
Condition: HIV Infections
Intervention: Drug: Etravirine (ETR)
15 Terminated Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naive
Condition: HIV-1 Infection
Interventions: Drug: BMS-986001;   Drug: Placebo matching with BMS-986001;   Drug: Efavirenz;   Drug: Lamivudine;   Drug: Tenofovir
16 Recruiting American Ginseng to Improve HIV-Associated Fatigue: A Randomized, Placebo-Controlled, Parallel Design, Multiple-Dose Clinical Trial
Condition: HIV/AIDS-associated Fatigue
Interventions: Drug: American ginseng;   Dietary Supplement: Placebo for American ginseng
17 Unknown  Evaluation of a Tailored Virtual Intervention to Empower Persons Living With HIV for Therapy Self-management
Condition: HIV
Intervention: Behavioral: VIH-TAVIE
18 Not yet recruiting Repeat Sexually Transmitted Infection (STI) Patients: Tailored Socio-Contextual Intervention to Reduce HIV Risk
Conditions: Sexually Transmitted Infection;   HIV
Interventions: Behavioral: Tailored Socio-Contextual Intervention;   Behavioral: Standard of Care
19 Unknown  Randomized Controlled Trial Using Patient Reported Outcomes and Care Managers to Improve HIV Medication Adherence in Routine Clinical Care
Condition: HIV
Intervention: Behavioral: Care management
20 Completed Men of African American Legacy Empowering Self
Condition: HIV
Interventions: Behavioral: Men of African American Legacy Empowering Self;   Behavioral: Standard HIV Education & Risk Reduction

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Indicates status has not been verified in more than two years